Robert Korngold
Robert Korngold
Chairman, Department of Research, Hackensack University Medical Center
Verified email at
Cited by
Cited by
Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.
R Korngold, J Sprent
The Journal of experimental medicine 148 (6), 1687-1698, 1978
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
C Sportès, FT Hakim, SA Memon, H Zhang, KS Chua, MR Brown, ...
The Journal of experimental medicine 205 (7), 1701-1714, 2008
Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.
J Sprent, M Schaefer, D Lo, R Korngold
The Journal of experimental medicine 163 (4), 998-1011, 1986
A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses
P Reddy, Y Maeda, C Liu, OI Krijanovski, R Korngold, JLM Ferrara
Nature medicine 11 (11), 1244-1249, 2005
Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells
JL Wang, ZJ Zhang, S Choksi, S Shan, Z Lu, CM Croce, ES Alnemri, ...
Cancer research 60 (6), 1498-1502, 2000
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+ 25+ T cells to allow an effective graft-versus-leukemia response
SC Jones, GF Murphy, R Korngold
Biology of Blood and Marrow Transplantation 9 (4), 243-256, 2003
T cell subsets and graft-versus-host disease
Transplantation 44 (3), 335-339, 1987
Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
BR Blazar, PA Taylor, A Panoskaltsis-Mortari, J Buhlman, J Xu, RA Flavell, ...
Journal of Immunology (Baltimore, Md.: 1950) 158 (1), 29-39, 1997
A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis
BA Jameson, JM McDonnell, JC Marini, R Korngold
Nature 368 (6473), 744-746, 1994
Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.
R Korngold, J Sprent
The Journal of experimental medicine 165 (6), 1552-1564, 1987
Recent advances in graft‐versus‐host disease (GVHD) prevention
BR Blazar, R Korngold
Immunological reviews 157 (1), 79-109, 1997
Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40: CD40L costimulatory pathway results in the generation of a potent immune regulatory cell
PA Taylor, TM Friedman, R Korngold, RJ Noelle, BR Blazar
Blood, The Journal of the American Society of Hematology 99 (12), 4601-4609, 2002
New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice
RJ Butterfield, JD Sudweeks, EP Blankenhorn, R Korngold, JC Marini, ...
The Journal of Immunology 161 (4), 1860-1867, 1998
Infusion of anti-B7. 1 (CD80) and anti-B7. 2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.
BR Blazar, AH Sharpe, PA Taylor, A Panoskaltsis-Mortari, GS Gray, ...
Journal of immunology (Baltimore, Md.: 1950) 157 (8), 3250-3259, 1996
Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited …
J Sprent, M Schaefer, EK Gao, R Korngold
The Journal of experimental medicine 167 (2), 556-569, 1988
Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis
FD Lublin, RL Knobler, B Kalman, M Goldhaber, J Marini, M Perrault, ...
Autoimmunity 16 (4), 267-274, 1993
Comparison of IgE and IgG antibody‐dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma
HJ Gould, GA Mackay, SN Karagiannis, CM O'Toole, PJ Marsh, BE Daniel, ...
European journal of immunology 29 (11), 3527-3537, 1999
Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
R Korngold, J Sprent
Journal of immunology (Baltimore, Md.: 1950) 135 (5), 3004-3010, 1985
Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers.
R Korngold, J Sprent
The Journal of experimental medicine 155 (3), 872-883, 1982
Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor
JM McDonnell, AJ Beavil, GA Mackay, BA Jameson, R Korngold, ...
Nature structural biology 3 (5), 419-426, 1996
The system can't perform the operation now. Try again later.
Articles 1–20